F19.988
Other psychoactive substance use, unspecified with other psychoactive substance-induced disorder
Clinical Classification Guidelines
Inclusion Terms
- Other (or unknown) substance-induced mild neurocognitive disorder, without use disorder
- Other (or unknown) substance-induced obsessive-compulsive or related disorder, without use disorder
Medical Intelligence & Overview
ICD-10 Code F19.988 refers to a condition where an individual experiences mental or behavioral health issues due to the use of unknown or unspecified psychoactive substances. This code captures a range of substance-induced disorders that do not fit into specific categories, including mild neurocognitive impairments and obsessive-compulsive or related behaviors caused by psychoactive substances. These disorders occur without the presence of a formal substance use disorder diagnosis, highlighting the complex effects that psychoactive substances can have on mental health.
Causes & Symptoms
Clinical Causes: Use of unidentified or unspecified psychoactive substances, which may include medications, recreational drugs, or other chemically active compounds. Accidental or intentional ingestion of unknown substances, possibly from contaminated or adulterated products. Exposure to substances that alter brain chemistry, leading to neurocognitive or behavioral changes. History of substance use where the specific substance was not well documented or is unknown.
Key Symptoms: Mild neurocognitive deficits, such as problems with memory, attention, or problem-solving skills. Obsessive-compulsive behaviors or related symptoms that seem to originate from substance effects. Changes in mood or behavior, including irritability, anxiety, or agitation. Difficulty concentrating or maintaining focus. Episodes of confusion or disorientation. Potential speech or language difficulties depending on the neurocognitive impact.
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a comprehensive assessment by healthcare professionals, including psychiatric evaluation and medical history review. Clinicians may perform neuropsychological testing and utilize imaging studies to determine cognitive impairments. The diagnosis of this disorder hinges on the temporal relationship between substance exposure and the development of neurocognitive or behavioral symptoms, with no other medical causes identified. It is important to distinguish these conditions from other cognitive or psychiatric disorders to ensure appropriate management.
Treatment Protocols: Treatment strategies typically focus on managing symptoms and preventing further substance use. Interventions may include: - Psychoeducation to inform the individual about the effects of psychoactive substances. - Supportive therapy to address behavioral and emotional changes. - Cognitive rehabilitation exercises to improve neurocognitive functioning. - Monitoring and managing any associated psychiatric symptoms, such as anxiety or depression. - Encouraging abstinence from unidentified substances to promote recovery. Because these disorders are caused by substance effects without a formal use disorder diagnosis, treatment often emphasizes symptomatic relief and avoiding further exposure to psychoactive substances.
Clinical Advice & FAQs
Billing Guidance
Is F19.988 a billable ICD-10 code?
Yes, F19.988 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F19.988?
Clinical documentation must specify the nature of Other psychoactive substance use, unspecified with other psychoactive substance-induced disorder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference